Newsletter | October 8, 2021

10.08.21 -- Going Precommercial -- From The Commercial World

 
Sponsor
Exclusive Articles
Going Precommercial: From The Commercial World
 
Nancy Lurker, a veteran Big Pharma marketer, now runs a small biopharma. And she admits, “The business models are very, very different.”
Skills I Learned That Have Helped Me As A Public Pharma CEO
 

While I learned a great deal about the industry in the latter part of my career, as a leader, my foundation was molded by the valuable lessons learned in two very different spaces — the U.S. Army Reserve and nursing.

What Are Your Thoughts Around The Unprecedented Growth Of Biopharmas Going Public During The Pandemic?
 

See the answer from Dennis Purcell, a founder and senior advisor of Aisling Capital.

Web-Exclusive Content
CMS Restructured The CAR-T DRG: What It Means For Manufacturers And Four Strategies Forward
 
In August 2021, the Centers for Medicare and Medicaid Services (CMS) expanded the chimeric antigen receptor T-cell (CAR-T) diagnosis-related group (DRG). While industry generally views this change as a positive development, significant uncertainties remain as to the specific immunotherapies included and how payment will change over time. To prepare, you should adjust your launch strategies.
Video
A Conversation On The Biopharma Cold Chain
 

In this executive virtual roundtable (EVR) section, Tim Valko, head of global manufacturing supply chain at Atara Biotherapeutics, provides his thoughts on the cold chain (temperature range of 2° C to 8° C ) and ultracold chain (-90° C to -60° C ) systems for transporting temperature-sensitive biopharmaceuticals.

Wooing Top Talent: Hiring And Recruiting Strategies For Life Science Companies
 

Competition for top talent in life sciences remains fierce. So how do companies set themselves apart? In this latest executive virtual roundtable (EVR), panelists discuss some of the current trends in hiring and recruiting, along with some best practices used in building out their teams. This EVR includes perspectives from Usama Malik, CEO, Fore Biotherapeutics, Paula Ragan, Ph.D., CEO, and cofounder, X4 Pharmaceuticals, Jonathan Rigby, CEO, Revolo Biotherapeutics, and Matt Toner, cofounder and CEO, LifeSci Search.

October 2021 Digital Edition
 

Inside you will find more on:

  • Industry Research
  • Regulatory Topics
  • Business Strategies
  • HR Tips

View the digital edition.

Contribute To Life Science Leader
Article Submission Guidelines
 

Think you have a good idea for an article that Life Science Leader readers would find valuable? Read these guidelines first before submitting your idea or your article to our editorial director.